We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Congressional Panel Hears Follow-on Biologics Debate
House Oversight and Reform Committee Chairman Henry Waxman (D-Calif.) has taken an interest in the debate over how
the FDA can approve follow-on biologics, holding a hearing on
the issue featuring scientists from the pharmaceutical industry.